Basic science and clinical outcomes studies from more than 10 countries show that Hydroxychloroquine works both before and after COVID-19 enters the cells. It increases zinc transport across the cell membrane, and the two work together to keep the virus from multiplying itself using our own cells’ machinery. There have been some significant developments and success stories with HCQ.

Yet, there are reports of medical professionals being threatened, and even in some cases their licenses under attack, from prescribing or suggesting the success of HCQ. CNN’s Elizabeth Cohen and Dr. Minali, went on the record, like so many others have with claims that tell a different story, President Trump is wrong in so many ways about hydroxychloroquine studies.” And then you may have seen the reports in the New York Times and others, claiming that President Trump has ‘Financial Interest’ in Hydroxychloroquine. The fact of the matter is, millions in America may have the same interest, in that it is through ‘twice removed’ mutual fund investments. The question needs to be asked, If President Trump had never said anything about the drug – would all this controversy still exist you think? Why do some people get deathly ill, and some die from COVID-19, and some people don’t feel sick at all?

Another factor that needs to be discussed is the World Health Organization and Dr. Tedros. The WHO took the extraordinary step of congratulating China; “The Chinese government is to be congratulated for the extraordinary measures it has taken to contain the outbreak. China is actually setting a new standard for outbreak response and it’s not an exaggeration.”

Elizabeth Lee Vliet, M.D. is an independent physician specializing in Preventive and Climacteric Medicine helping women and men from puberty to late life with overlooked hormone connections affecting health risks and vitality. Dr. Vliet has been a powerful advocate for patients, speaking nationally and internationally on health and wellness, medical freedom, and free market medicine to help lower costs and increase patient choices.


Subscribe to

Or subscribe with your favorite app by using the address below